In the UK, 13,682 people were diagnosed with NHL in 2015.[3] In the US, it was estimated that approximately 74,680 new cases of NHL and 19,910 deaths caused by NHL would occur in 2018.[4] In the US, NHL is estimated to be the seventh most commonly diagnosed cancer, and the ninth leading cause of cancer-related death.[4] It is more common in males than in females, and more common in white people than in black or Hispanic people. NHL is less common in Asian populations, in whom the T-cell subtype is more prevalent. The incidence of lymphomas increases with age. They are uncommon before age 50 years. First-degree relatives of patients with NHL are at approximately 1.7-times increased risk of developing NHL[5]

BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.

To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.

You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.

Use of this content is subject to our disclaimer